Viewing Study NCT07037420


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2025-12-26 @ 3:04 AM
Study NCT ID: NCT07037420
Status: RECRUITING
Last Update Posted: 2025-12-12
First Post: 2025-05-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly
Sponsor: Alexion Pharmaceuticals, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-10-28
Start Date Type: ACTUAL
Primary Completion Date: 2027-01-19
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-11-11
Completion Date Type: ESTIMATED
First Submit Date: 2025-05-27
First Submit QC Date: None
Study First Post Date: 2025-06-25
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-12-10
Last Update Post Date: 2025-12-12
Last Update Post Date Type: ESTIMATED